IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.

BACKGROUND Sera of patients with IgA nephropathy (IgAN) contain circulating immune complexes (CIC) composed of galactose-deficient IgA1 complexed with antiglycan antibodies. The role of these CIC in the pathogenesis of IgAN is not known. METHODS We studied how proliferation of cultured mesangial cells (MC) is affected by CIC prepared from sera of IgAN patients and healthy control subjects using size-exclusion chromatography. CIC-containing fractions were added to serum-starved MC in culture, and cell proliferation was measured using (3)H-thymidine incorporation. The results were confirmed by staining MC using an antibody against proliferating cell nuclear antigen. RESULTS The incubation of starved MC with serum fractions with M(r) 800 to 900 kD, rich with galactose-deficient IgA1, stimulated proliferation, while fractions with smaller complexes were inhibitory. Furthermore, CIC-containing larger molecular mass fractions isolated from serum of an IgAN patient collected during an episode of macroscopic hematuria stimulated MC proliferation more than CIC obtained during a subsequent quiescent phase. To examine the role of IgA, we removed IgA1 from serum before fractionation. The resultant IgA1-depleted fractions were devoid of stimulatory IgA-CIC. Sera of IgAN patients were also fractionated after addition of desialylated galactose-deficient polymeric IgA1 to form additional immune complexes. Supplementation with a small quantity of this IgA1 increased cellular proliferation in assays using serum fractions of M(r)>/=800 to 900 kD; uncomplexed IgA1 did not affect MC proliferation significantly. In contrast, supplementation with a larger quantity of this IgA1 inhibited cellular proliferation in assays using serum fractions of M(r) 700 to 800 kD. CONCLUSION Overall, these findings suggest that CIC containing aberrantly glycosylated IgA1 affect proliferation of MC in vitro and, thus, likely play a role in the pathogenesis of IgAN.

[1]  M. Hardy,et al.  Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. , 1982, Transplantation.

[2]  J. Mestecky,et al.  Polyethylene glycol precipitates of serum contain a large proportion of uncomplexed immunoglobulins and C3. , 1996, Immunological investigations.

[3]  E. Haddad,et al.  Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.

[4]  J. Barratt,et al.  Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. , 2001, Kidney international.

[5]  B. Julian,et al.  Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. , 1997, Kidney international.

[6]  B. Julian,et al.  Interactions of human mesangial cells with IgA and IgA-containing immune complexes. , 2002, Kidney international.

[7]  B. Julian,et al.  Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. , 1986, The Journal of clinical investigation.

[8]  Y. Hiki,et al.  Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. , 1999, Journal of the American Society of Nephrology : JASN.

[9]  R. Goldblum,et al.  IgA induced activation of human mesangial cells: Independent of FcαR1 (CD 89) , 1998 .

[10]  S. Harper,et al.  Galactosylation of N‐ and O‐linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy , 1995, Clinical and experimental immunology.

[11]  J. Egido,et al.  Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy. , 1989, Clinical and experimental immunology.

[12]  Janet M. Allen,et al.  Expression of Fc α/μ receptor by human mesangial cells: A candidate receptor for immune complex deposition in IgA nephropathy , 2002 .

[13]  J. Feehally,et al.  Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  H. Nakauchi,et al.  Fcα/μ receptor mediates endocytosis of IgM-coated microbes , 2000, Nature Immunology.

[15]  A. Michael,et al.  Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. , 1980, The Journal of clinical investigation.

[16]  B. Julian,et al.  Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific. , 1993, Kidney international.

[17]  Y. Hiki,et al.  Exposed peptide core of IgA1 hinge region in IgA nephropathy. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  G. Mazzucco,et al.  IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. , 1984, Clinical and experimental immunology.

[19]  R. Coppo,et al.  Aberrant glycosylation in IgA nephropathy (IgAN). , 2004, Kidney international.

[20]  G. Mazzucco,et al.  Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity. , 1982, Clinical nephrology.

[21]  D. Chevet,et al.  Impairment of jacalin binding to serum IgA in IgA nephropathy , 1990, Journal of clinical laboratory analysis.

[22]  M. Schönermark,et al.  Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. , 1991, International archives of allergy and applied immunology.

[23]  A. Allen.  Abnormal glycosylation of IgA: is it related to the pathogenesis of IgA nephropathy? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  Y. Hiki,et al.  O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role. , 1995, Contributions to nephrology.

[25]  J. Feehally,et al.  IgA glycosylation in IgA nephropathy. , 1998, Advances in experimental medicine and biology.

[26]  M. Cooper,et al.  Identification of the Transferrin Receptor as a Novel Immunoglobulin (Ig)a1 Receptor and Its Enhanced Expression on Mesangial Cells in Iga Nephropathy , 2001, The Journal of experimental medicine.

[27]  B. Julian,et al.  Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. , 1993, Contributions to nephrology.

[28]  K. Resch,et al.  Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. , 1987, Journal of immunology.

[29]  R. Monteiro,et al.  IgA Fc receptors. , 2003, Annual review of immunology.

[30]  J. Thompson,et al.  Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection. , 1996, Transplantation.

[31]  J. Wynne,et al.  EXAMINATION OF THE ANUS IN SUSPECTED CHILD SEXUAL ABUSE , 1986, The Lancet.

[32]  M. Daha,et al.  Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). , 1999, Journal of the American Society of Nephrology : JASN.

[33]  K. Lai,et al.  Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. , 2000, Journal of the American Society of Nephrology : JASN.

[34]  B. Julian,et al.  Heterogeneity of carbohydrate moieties of IgA1 molecules from IgA nephropathy patients and normal individuals , 1997 .

[35]  L. Peruzzi,et al.  Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. , 2001, Journal of the American Society of Nephrology : JASN.

[36]  R. Coppo,et al.  IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  K. Lai,et al.  Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  E. Haddad,et al.  Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: association between CD71 expression and IgA deposits. , 2003, Journal of the American Society of Nephrology : JASN.

[39]  B. Julian,et al.  Progress in the pathogenesis of IgA nephropathy. , 1999, Advances in nephrology from the Necker Hospital.

[40]  P. Youinou,et al.  Aberrant glycosylation of IgA from patients with IgA nephropathy , 1996, Glycoconjugate Journal.

[41]  K. Toma,et al.  Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  B. Julian,et al.  Progress in Molecular and Genetic Studies of IgA Nephropathy , 2001, Journal of Clinical Immunology.

[43]  B. Julian,et al.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. , 1999, The Journal of clinical investigation.

[44]  R. Levinsky,et al.  IgA IMMUNE COMPLEXES IN HENOCH-SCHÖNLEIN PURPURA , 1979, The Lancet.

[45]  J. Floege,et al.  IgA nephropathy: recent developments. , 2000, Journal of the American Society of Nephrology : JASN.

[46]  J. Barratt,et al.  Identification of a novel Fcα receptor expressed by human mesangial cells , 2000 .

[47]  A. Woodroffe,et al.  The effect of IgA immune complexes on the proliferation of cultured human mesangial cells. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  B. Julian,et al.  IgA nephropathy: an update , 2004, Current opinion in nephrology and hypertension.

[49]  B. Julian,et al.  Pathogenic potential of galactose‐deficient IgA1 in IgA nephropathy , 2002 .

[50]  Y. Hiki,et al.  Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. , 2001, Kidney international.

[51]  W. Couser,et al.  Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro. , 2001, Kidney international.

[52]  A. Woodroffe,et al.  Recurrent mesangial IgA nephritis following renal transplantation. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  K. Lai,et al.  Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy? , 1999, The Journal of laboratory and clinical medicine.

[54]  S. Harper,et al.  Nephrology Dialysis Transplantation Leucocyte B1,3 Galactosyltransferase Activity in Iga Nephropathy , 2022 .